These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 6176924

  • 1. Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease.
    Weed JC, Barnard DE, Currie JL, Clayton LA, Hammond CB.
    Obstet Gynecol; 1982 Mar; 59(3):377-80. PubMed ID: 6176924
    [Abstract] [Full Text] [Related]

  • 2. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL, Blessing JA, DiSaia PJ, Soper JT, Twiggs LB.
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A new combination chemotherapy for resistant trophoblastic disease.
    Surwit EA, Suciu TN, Schmidt HJ, Hammond CB.
    Gynecol Oncol; 1979 Aug; 8(1):110-8. PubMed ID: 222651
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
    Kohorn EI.
    Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
    [Abstract] [Full Text] [Related]

  • 14. [Methotrexate in gynecologic oncology].
    Isonishi S, Terashima Y.
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Placental site trophoblastic tumor: an overview.
    Bonazzi C, Urso M, Dell'Anna T, Sacco S, Buda A, Cantú MG.
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [Abstract] [Full Text] [Related]

  • 17. Management of high-risk gestational trophoblastic disease.
    Surwit EA.
    J Reprod Med; 1987 Sep; 32(9):657-62. PubMed ID: 2822919
    [Abstract] [Full Text] [Related]

  • 18. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE, Braga CA.
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
    Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez G, Hammond CB.
    Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.